1. Academic Validation
  2. The structure of vanin 1: a key enzyme linking metabolic disease and inflammation

The structure of vanin 1: a key enzyme linking metabolic disease and inflammation

  • Acta Crystallogr D Biol Crystallogr. 2014 Dec 1;70(Pt 12):3320-9. doi: 10.1107/S1399004714022767.
Ykelien L Boersma 1 Janet Newman 2 Timothy E Adams 2 Nathan Cowieson 3 Guy Krippner 4 Kiymet Bozaoglu 4 Thomas S Peat 2
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
  • 2 CSIRO Biosciences Program, 343 Royal Parade, Parkville, VIC 3052, Australia.
  • 3 Australian Synchrotron, 800 Blackburn Road, Clayton, VIC 3168, Australia.
  • 4 Baker IDI, 75 Commercial Road, Melbourne, VIC 3004, Australia.
Abstract

Although part of the coenzyme A pathway, vanin 1 (also known as pantetheinase) sits on the cell surface of many cell types as an ectoenzyme, catalyzing the breakdown of pantetheine to pantothenic acid (vitamin B5) and cysteamine, a strong reducing agent. Vanin 1 was initially discovered as a protein involved in the homing of leukocytes to the thymus. Numerous studies have shown that vanin 1 is involved in inflammation, and more recent studies have shown a key role in Metabolic Disease. Here, the X-ray crystal structure of human vanin 1 at 2.25 Å resolution is presented, which is the first reported structure from the vanin family, as well as a crystal structure of vanin 1 bound to a specific inhibitor. These structures illuminate how vanin 1 can mediate its biological roles by way of both enzymatic activity and protein-protein interactions. Furthermore, it sheds light on how the enzymatic activity is regulated by a novel allosteric mechanism at a domain interface.

Keywords

CoA biosynthesis; colitis; inflammation; metabolic disease; vanin 1.

Figures